Cancel anytime
CorVel Corp (CRVL)CRVL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: CRVL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -3.25% | Upturn Advisory Performance 2 | Avg. Invested days: 32 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -3.25% | Avg. Invested days: 32 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.40B USD |
Price to earnings Ratio 70.04 | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) 4.5 |
Volume (30-day avg) 30505 | Beta 1.09 |
52 Weeks Range 187.92 - 325.00 | Updated Date 09/18/2024 |
Company Size Mid-Cap Stock | Market Capitalization 5.40B USD | Price to earnings Ratio 70.04 | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) 4.5 | Volume (30-day avg) 30505 | Beta 1.09 |
52 Weeks Range 187.92 - 325.00 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.55% | Operating Margin (TTM) 13.24% |
Management Effectiveness
Return on Assets (TTM) 13.51% | Return on Equity (TTM) 33.14% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 70.04 | Forward PE - |
Enterprise Value 5291439556 | Price to Sales(TTM) 6.61 |
Enterprise Value to Revenue 6.48 | Enterprise Value to EBITDA 42.56 |
Shares Outstanding 17131200 | Shares Floating 9192084 |
Percent Insiders 46.45 | Percent Institutions 54.04 |
Trailing PE 70.04 | Forward PE - | Enterprise Value 5291439556 | Price to Sales(TTM) 6.61 |
Enterprise Value to Revenue 6.48 | Enterprise Value to EBITDA 42.56 | Shares Outstanding 17131200 | Shares Floating 9192084 |
Percent Insiders 46.45 | Percent Institutions 54.04 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Company Profile:
CorVel Corp is a healthcare management company based in Irvine, California. The company was founded in 1987 by Gordon Clemons and specializes in providing medical cost containment and managed care services for workers' compensation, auto and liability, and group health insurance markets. CorVel Corp's core business areas include bill review, case management, utilization management, and preferred provider networks.
The leadership team of CorVel Corp is led by its CEO, Michael Combs, who has been with the company since 2004. The company's corporate structure includes various departments such as finance, operations, sales, and marketing, all working together to deliver cost-effective healthcare solutions to its clients.
Top Products and Market Share:
CorVel Corp's top products include its bill review services, case management programs, and utilization management services. These offerings have positioned the company as a leader in the medical cost containment industry, with a significant market share in the US healthcare market. The company's focus on customer service and innovative solutions has helped it maintain a competitive edge against other players in the industry.
Total Addressable Market:
The total addressable market for CorVel Corp includes the vast healthcare industry in the US, with a particular focus on workers' compensation, auto and liability, and group health insurance markets. With the rising cost of healthcare in the country, the demand for cost-effective managed care solutions is expected to continue growing, presenting significant opportunities for the company.
Financial Performance:
In terms of financial performance, CorVel Corp has shown consistent growth in revenue and net income over the years. The company's profit margins and earnings per share (EPS) have also remained strong, reflecting its efficient cost management and operational excellence. Year-over-year comparisons show steady financial growth, with positive cash flow statements and a healthy balance sheet indicating the company's financial stability.
Dividends and Shareholder Returns:
CorVel Corp has a history of paying dividends to its shareholders, with a track record of consistent payouts and attractive dividend yields. Shareholder returns have been positive over various time periods, showcasing the company's commitment to delivering value to its investors.
Growth Trajectory:
The historical growth analysis of CorVel Corp over the past 5 to 10 years has been impressive, with the company expanding its market presence and product offerings through strategic initiatives and acquisitions. Future growth projections are optimistic, driven by industry trends and the company's focus on innovation and customer service. Recent product launches and partnerships are expected to further fuel the company's growth trajectory in the coming years.
Market Dynamics: CorVel Corp operates in a dynamic healthcare industry, with current trends focused on cost containment, quality care delivery, and technological advancements. The company is well-positioned within the industry, with its adaptive approach to market changes and customer-centric solutions distinguishing it from competitors.
Competitors:
Key competitors of CorVel Corp include Crawford & Company (CRD), PROS Holdings, Inc. (PRO), and HMS Holdings Corp (HMSY). While market share percentages may vary, CorVel Corp's strong customer relationships and innovative services provide a competitive advantage against these rivals. The company's focus on quality care outcomes and cost-effective solutions has helped it maintain its position as a market leader.
Potential Challenges and Opportunities:
Key challenges for CorVel Corp include navigating regulatory changes, adapting to technological advancements, and managing competitive pressures in the industry. However, potential opportunities such as expanding into new markets, introducing innovative products, and forming strategic partnerships present avenues for growth and development for the company.
Recent Acquisitions (last 3 years):
In the last 3 years, CorVel Corp has made several acquisitions to enhance its service offerings and market presence. One notable acquisition was that of Accord Imaging in 2019, which helped the company expand its diagnostic imaging capabilities and strengthen its position in the healthcare market. The acquisition was made to leverage Accord Imaging's expertise in medical imaging and provide additional value to CorVel Corp's clients.
AI-Based Fundamental Rating:
Based on an AI-based rating system, CorVel Corp's stock fundamentals receive a rating of 8 out of 10. This high rating is justified by the company's strong financial health, market position, and future growth prospects. With a solid track record of revenue growth and profitability, coupled with innovative solutions and strategic acquisitions, CorVel Corp is well-positioned for continued success in the healthcare management industry.
Sources and Disclaimers:
The information for this analysis was gathered from CorVel Corp's official website, financial reports, and reputable financial news sources such as Bloomberg and CNBC. It is important to note that this overview is for informational purposes only and should not be used as financial advice for investment decisions. Investors are advised to conduct their own research and consult with a financial advisor before making any investment choices.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CorVel Corp
Exchange | NASDAQ | Headquaters | Fort Worth, TX, United States |
IPO Launch date | 1991-06-28 | President & CEO | Mr. Michael G. Combs |
Sector | Financial Services | Website | https://www.corvel.com |
Industry | Insurance Brokers | Full time employees | 4870 |
Headquaters | Fort Worth, TX, United States | ||
President & CEO | Mr. Michael G. Combs | ||
Website | https://www.corvel.com | ||
Website | https://www.corvel.com | ||
Full time employees | 4870 |
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.